Skip to main content
Share Us:
Subscribe
|
Contact
Main menu
Home
About
About the Journal
Editorial Board
Role of Associate & Senior Editors
Board Disclosures
Supplemental Issues
Advertising
Subscribe
Recommend JAD
Related Links
Related IOS Press Journals
Upcoming Meetings
Contact
News
Submit
For Authors
Submission Guidelines
Submission Letter and Manuscript Transmission
Manuscript Preparation
Submission Checklist
Copyright
Permissions
Review Process
Publication Fee / Open Access Option
Proofs/Reprints
Policies
Financial Disclosure
Open Access Mandates
Preprints/Preprint Servers
Policy on Use of Human Subjects
Policy on Animal Use
Policy on Ethics
Contents
Current Issue
All Issues (including upcoming)
OnlineFirst Articles
Books
Letters to the Editor
Blog
Members
Rankings/Awards
Journal of Alzheimer's Disease Reports
Search JAD
User Top Menu
Welcome, Guest
Join
Log In
Main menu
Home
About
News
Submit
Contents
Blog
Members
Rankings/Awards
Journal of Alzheimer's Disease Reports
Home
About
About the Journal
Editorial Board
Role of Associate & Senior Editors
Board Disclosures
Supplemental Issues
Advertising
Subscribe
Recommend JAD
Related Links
Related IOS Press Journals
Upcoming Meetings
Contact
News
Submit
For Authors
Submission Guidelines
Submission Letter and Manuscript Transmission
Manuscript Preparation
Submission Checklist
Copyright
Permissions
Review Process
Information For Reviewers
Role of Associate & Senior Editors
Publication Fee / Open Access Option
Proofs/Reprints
Pre-Press/Proofs
Reprints
Policies
Financial Disclosure
Open Access Mandates
Preprints/Preprint Servers
Policy on Use of Human Subjects
Policy on Animal Use
Policy on Ethics
Contents
Current Issue
All Issues (including upcoming)
OnlineFirst Articles
Books
Letters to the Editor
Blog
Blog Guidelines
Members
Rankings/Awards
Alzheimer Award
Top 100
Top 100 Most Cited AD Investigators
Top 100 Most Prolific AD Investigators
The Article
Top 50 Results
Journal of Alzheimer's Disease Reports
Contents
Homepage
You are here
Home
Slavica Krantic, PhD
Primary tabs
View
(active tab)
Nodes
JAD profile
Affiliation(s):
INSERM U938
;
Centre de Recherche St Antoine
Lab URL:
https://www.crsa.fr/
Areas of Interest:
aging, Alzheimer’s disease, amyloid, cell death, cell cycle, hippocampus, mitochondria, neurodegeneration
Site Participation
Cognitive reserve in ageing and Alzheimer's disease.
March 4, 2016
The review provides a comprehensive overview of the "state of the art" about the cognitive reserve. Most importantly, it...
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
March 4, 2016
Very useful for the clarification of terms and concepts used in the study of preclinical stage of AD.
Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.
March 4, 2016
This work presents the data indicating that optimal (neither too low, nor excess) hippocampal activation is required for normal...
Caspase signalling controls microglia activation and neurotoxicity.
March 4, 2016
This paper is important since it brings evidence suggesting that caspase activation previously detected in biochemical studies...
Plasma phospholipids identify antecedent memory impairment in older adults.
March 4, 2016
The authors propose and validate the plasma phospholipid content as an attractive option for preclinical AD diagnostic marker....
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.
March 4, 2016
The fact that aggregated amyloid-beta is not a potent activator of mouse complement system is often forgotten when studying AD-...
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
March 4, 2016
The authors present the evidence that tauopathy may begin in sporadic AD much earlier than initially thought. They suggest that...
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
March 4, 2016
This paper reports on the identification of A673T mutation in the APP gene yielding protection against Alzheimer's disease and...
Site Participation